Dose escalation study of Olaparib in addition to cisplatin based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)

2013 ◽  
Author(s):  
Dymphna Lee
Sign in / Sign up

Export Citation Format

Share Document